The Chemours Company

https://www.chemours.com/en

The Chemours Company is an American chemical company headquartered in Wilmington, Delaware. Established in July 2015 as a spin-off from DuPont, it operates as a global provider of performance chemicals. Its mission is to create a colorful, capable, and cleaner world through the power of chemistry, delivering trusted chemistry that makes lives better and helps communities thrive.

Chemours' core business is structured around three main segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The company is a significant producer of titanium dioxide, marketed under the Ti-Pure™ brand, and offers a range of fluoroproducts including refrigerants like Opteon™ and Freon™, as well as industrial fluoropolymer resins and derivatives such as Teflon™, Viton™, Nafion™, and Krytox™. These products serve diverse industries including coatings, plastics, refrigeration, air conditioning, transportation, semiconductor and advanced electronics, and automotive.

In recent news, The Chemours Company completed a $700 million private offering of senior unsecured notes due 2034 in March 2026. The company's stock reached a 52-week high in May 2026, reflecting strong investor confidence and performance, with analysts forecasting a return to profitability. Chemours continues to focus on strategic initiatives, including innovation in low global warming potential refrigerants and high-performance polymers for emerging markets like electric vehicles and semiconductors, while also navigating ongoing environmental and PFAS-related litigation. Denise Dignam serves as the President and CEO.

Latest updates

Chemours Refinances Debt, Shifting Maturity Profile

Event summary

  • Chemours completed a $700 million private offering of 7.875% senior unsecured notes due 2034.
  • Proceeds were used to redeem $188 million of 5.750% notes due 2028 and will fund the redemption of $500.3 million of 5.375% notes due 2027.
  • The offering was exempt from registration and targeted qualified institutional buyers and non-U.S. persons.
  • Chemours used a treasury rate of 3.56% to estimate the redemption price of the 2027 notes.

The big picture

Chemours is actively reshaping its debt profile, extending maturities and managing interest rate risk. This move signals a proactive approach to financial stability, but also reflects the challenges of maintaining attractive financing terms given the company’s operational and legal complexities. The $700 million offering demonstrates Chemours’ continued reliance on capital markets to manage its balance sheet.

What we're watching

Cost of Capital
The higher interest rate on the new notes (7.875% vs. the redeemed notes) suggests increased borrowing costs, potentially impacting future profitability and investment decisions.
Debt Structure
Chemours’ ongoing debt management strategy will be key to monitor, particularly given the company’s history of environmental liabilities and potential future claims.
Liquidity
The use of existing cash reserves to fund the redemptions warrants observation; future capital needs may necessitate further financing activities.

Chemours Upsizes Debt Offering to Refinance Existing Notes

Event summary

  • Chemours priced a private offering of $700 million in new 7.875% senior notes due 2034, up from a previously announced $600 million.
  • The notes mature on March 15, 2034, and pay interest semi-annually.
  • Proceeds will be used to redeem $5.375% senior notes due 2027 and partially redeem $5.750% senior notes due 2028.
  • The offering is targeted at qualified institutional buyers and non-U.S. persons.

The big picture

Chemours' decision to upsize the debt offering and refinance existing notes highlights the ongoing need for the company to manage its capital structure. The 7.875% coupon rate, while reflecting current market conditions, represents a significant cost of capital for a company operating in a cyclical industry. This move signals a focus on near-term debt obligations while potentially limiting future investment flexibility.

What we're watching

Debt Load
The increased offering size suggests Chemours may be facing challenges in securing more favorable refinancing terms, potentially reflecting concerns about its financial leverage.
Market Conditions
The success of Chemours' ability to maintain this interest rate on future debt offerings will depend on broader credit market conditions and investor sentiment towards the chemical sector.
Redemption Impact
The partial redemption of the 2028 notes indicates a strategic prioritization of debt obligations, and the impact on Chemours' remaining financial flexibility warrants monitoring.

Chemours Refinances Debt, Targets Note Redemptions with $600 Million Offering

Event summary

  • Chemours announced a private offering of $600 million in senior notes due 2034.
  • Proceeds will be used to redeem $537.5 million in 5.375% notes due 2027 and repurchase a portion of $575 million in 5.750% notes due 2028.
  • The notes are being offered to qualified institutional buyers or non-U.S. persons in compliance with Regulation S.
  • The offering is subject to market conditions and has not been registered under the Securities Act.

The big picture

Chemours is actively managing its debt obligations through this private placement, a common strategy for companies seeking to optimize their capital structure. The move to refinance shorter-term debt with longer-dated notes indicates a desire to lock in current interest rates and reduce near-term refinancing risk. This action signals a focus on financial stability amidst ongoing volatility in the industrial chemicals sector.

What we're watching

Interest Rate Risk
The success of this refinancing hinges on Chemours' ability to secure favorable interest rates, which will be influenced by broader macroeconomic conditions and investor sentiment.
Debt Maturity
The accelerated redemption of the 2027 notes suggests a desire to proactively manage near-term debt obligations and reduce refinancing risk.
Credit Rating
The scale of this offering and its impact on Chemours' debt profile will be closely scrutinized by rating agencies, potentially influencing future credit ratings.

Chemours, 2CRSi Partner to Accelerate Two-Phase Liquid Cooling Adoption

Event summary

  • Chemours and 2CRSi have entered into a Joint Development Agreement (JDA) following successful qualification of Chemours’ Opteon™ fluid in 2CRSi servers.
  • The partnership aims to accelerate the development and deployment of two-phase cooling technologies for high-density IT infrastructure, supporting AI and next-generation chips.
  • 2CRSi’s Atlas 1.8GG 2PIC server model, utilizing Chemours’ fluid, currently houses 8 NVIDIA H200 GPUs in a 1U format.
  • Chemours’ Opteon™ fluid can reduce data center cooling energy by up to 90% and achieve a PUE approaching 1.
  • 2CRSi is listed on the Euronext Growth market (ISIN code: FR0013341781).

The big picture

The partnership reflects the escalating energy demands of AI and GPU-accelerated computing, which are straining traditional air-cooling infrastructure. Two-phase liquid cooling offers a compelling solution for high-density deployments, but its adoption has been limited by cost and complexity. This collaboration aims to overcome these barriers and unlock a significant market opportunity for both companies, particularly as edge data centers proliferate.

What we're watching

Market Adoption
The pace at which two-phase liquid cooling is adopted across the broader data center market will depend on the willingness of operators to invest in new infrastructure and overcome potential compatibility challenges with existing IT components.
Competitive Landscape
How Chemours and 2CRSi’s combined expertise will position them against other liquid cooling solution providers, particularly those offering alternative cooling technologies, will be a key indicator of success.
Fluid Scalability
Whether Chemours can scale Opteon™ fluid production to meet the anticipated demand from 2CRSi and other potential customers will be critical to realizing the partnership's full potential.

Chemours Executive Joins SEMI Board Amid Semiconductor Supply Chain Focus

Event summary

  • Gerardo Familiar, President of Chemours' Advanced Performance Materials (APM) business, has been appointed to the SEMI North America Advisory Board (NAAB).
  • The appointment began on January 14, 2026, and marks the start of a three-year term.
  • Chemours' APM business provides high-performance fluoropolymers critical to semiconductor manufacturing.
  • SEMI represents thousands of companies across the semiconductor and electronics supply chain.

The big picture

Chemours' appointment of its APM President to the SEMI NAAB signals a deepening commitment to the semiconductor industry, a sector experiencing significant growth and ongoing supply chain challenges. This move positions Chemours to directly influence industry standards and potentially secure preferential access to key customers. The timing aligns with broader efforts to onshore semiconductor manufacturing and bolster North American supply chain resilience, a priority for governments and industry players alike.

What we're watching

Strategic Alignment
The extent to which Familiar's presence on the SEMI NAAB will influence Chemours' product development and market access strategies within the semiconductor sector warrants observation.
Supply Chain Dynamics
How Chemours leverages its advisory role to navigate ongoing supply chain vulnerabilities and potential geopolitical risks impacting semiconductor material sourcing will be a key indicator.
Competitive Landscape
Whether Chemours' increased involvement in SEMI's initiatives will provide a competitive advantage over other materials suppliers vying for share in the semiconductor market needs to be assessed.

Chemours Swings to Loss on Cyclical Headwinds, Announces Kuan Yin Site Sale

Event summary

  • Chemours reported a net loss of $386 million, or $2.57 per diluted share, in 2025, compared to a net income of $69 million the prior year.
  • The company sold its Kuan Yin TiO2 site for approximately $3004 million in net proceeds, expected to boost cash inflow in 2026.
  • Adjusted EBITDA decreased to $742 million in 2025, down from $768 million in 2024, due to cyclical headwinds in the Advanced Performance Materials (APM) business and lower Titanium Technologies (TT) pricing.
  • TSS (Thermal & Specialized Solutions) reported record annual sales with double-digit growth in Opteon™ Refrigerants, offsetting weakness in other segments.

The big picture

Chemours' 2025 results highlight the vulnerability of specialty chemical companies to cyclical end markets, particularly those reliant on industrial demand. The sale of the Kuan Yin TiO2 site signals a strategic shift towards prioritizing cash flow and debt reduction, potentially at the expense of long-term growth initiatives. The company's performance is increasingly tied to the success of its Opteon™ refrigerant transition and its ability to navigate evolving regulatory landscapes.

What we're watching

Market Recovery
Whether the cyclical headwinds impacting the APM business will abate and allow for a rebound in performance, or if Chemours will need to further prioritize cash flow over growth.
Pricing Power
How effectively Chemours can sustain the TiO2 price increases implemented in December 2025, given ongoing competitive pressures and potential shifts in demand.
Debt Profile
The company’s ability to utilize the proceeds from the Kuan Yin site sale to meaningfully reduce its debt and improve its leverage ratio, bringing it closer to its target of below three times adjusted EBITDA.

Chemours Resumes Dividend Payments After Years of Litigation

Event summary

  • The Chemours Company's board declared a quarterly cash dividend of $0.0875 per share.
  • The dividend will be paid on March 13, 2026.
  • The record date for shareholders receiving the dividend is February 27, 2026.
  • Chemours operates three business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.

The big picture

Chemours' dividend declaration marks a significant shift, signaling a return to shareholder returns after a period dominated by legal battles and restructuring. The move suggests a degree of confidence in the company’s future earnings potential and ability to navigate ongoing regulatory and legal challenges. The dividend amount, while modest, represents a commitment to capital allocation and a potential signal to investors about the company's long-term outlook.

What we're watching

Financial Health
The resumption of dividends signals improved financial stability after years of litigation and restructuring costs, but the sustainability of this payout will depend on continued operational performance and favorable legal outcomes.
Capital Allocation
Management’s decision to prioritize dividends over other potential uses of capital, such as acquisitions or share buybacks, will reveal their confidence in Chemours’ future growth prospects and ability to manage risk.
Litigation Risk
While the dividend resumption is positive, ongoing litigation related to PFAS chemicals could still significantly impact Chemours’ financial performance and ability to maintain dividend payments.

Chemours to Pocket $360 Million from Taiwan Land Sale

Event summary

  • Chemours has agreed to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan.
  • The sale is expected to generate approximately $360 million in gross cash proceeds.
  • The transaction is slated to close by mid-year 2026, pending regulatory approval and environmental conditions.
  • Chemours intends to use the proceeds to reduce its debt obligations.

The big picture

This divestiture represents a significant liquidity event for Chemours, allowing the company to address its debt load and potentially fund other strategic initiatives. The sale to Century Wind Power and Century Iron & Steel suggests a shift in land use priorities in Taiwan, with a move towards renewable energy and industrial development. The $360 million price tag underscores the remaining value in Chemours’ asset base, even as it continues to shed legacy operations.

What we're watching

Environmental Scrutiny
The deal's closure hinges on regulatory approval, including environmental conditions, which could introduce delays or require remediation costs beyond the initially stated proceeds.
Debt Impact
The actual impact on Chemours' debt profile will depend on the final net proceeds after taxes and fees, and how aggressively the company applies the funds to debt repayment.
Strategic Shift
Chemours' decision to exit Taiwan, coupled with the buyer's focus on wind power and steel, signals a potential realignment of Chemours' geographic footprint and product portfolio away from legacy TiO2 assets.

Chemours Overhauls Titanium Technologies Leadership Amidst Transformation

Event summary

  • Michael Foley will assume the role of President of Chemours Titanium Technologies (TT) effective February 2026.
  • Damián Gumpel is departing Chemours, marking a leadership change within the TT division.
  • Foley previously served as President & General Manager of the Formulated Specialties Business at Momentive Performance Materials, overseeing a $1 billion portfolio.
  • Denise Dignam, Chemours President and CEO, will provide interim leadership support to TT during the transition.
  • Chemours Titanium Technologies is a leading global manufacturer of titanium dioxide (TiO₂).

The big picture

The appointment of Foley, with his experience in portfolio optimization and restructuring, signals Chemours is intensifying efforts to improve the performance of its Titanium Technologies division. The departure of Gumpel, coupled with Dignam’s immediate involvement, suggests a deeper strategic review is underway. Chemours' TT business, as a major TiO₂ producer, operates in a cyclical market sensitive to global coatings and plastics demand, making operational efficiency and strategic agility paramount.

What we're watching

Execution Risk
Foley's success will hinge on his ability to rapidly integrate into Chemours and execute the existing 'Pathway to Thrive' strategy, given the immediate leadership support from the CEO.
Governance Dynamics
The timing of Gumpel’s departure and the immediate need for Dignam’s involvement suggest potential underlying issues within TT that investors should investigate further.
Market Positioning
The stated focus on delivering 'strong business results' indicates Chemours may be facing margin pressure or competitive challenges within the TiO₂ market, and Foley’s operational expertise will be critical to addressing these.
CID: 631